They have discovered a way to transform skin cells into mature, fully functioning liver cells that flourish on their own, even after being transplanted into laboratory animals modified to mimic liver failure
The power of regenerative medicine now allows scientists to transform skin cells into cells that closely resemble heart cells, pancreas cells and even neurons. However, a method to generate cells that are fully mature—a crucial prerequisite for life-saving therapies—has proven far more difficult. But now, scientists at the Gladstone Institutes and the University of California, San Francisco (UCSF), have made an important breakthrough: they have discovered a way to transform skin cells into mature, fully functioning liver cells that flourish on their own, even after being transplanted into laboratory animals modified to mimic liver failure.
In previous studies on liver-cell reprogramming, scientists had difficulty getting stem cell-derived liver cells to survive once being transplanted into existing liver tissue. But the Gladstone-UCSF team figured out a way to solve this problem. Writing in the latest issue of the journal Nature, researchers in the laboratories of Gladstone Senior Investigator Sheng Ding, PhD, and UCSF Associate Professor Holger Willenbring, MD, PhD, reveal a new cellular reprogramming method that transforms human skin cells into liver cells that are virtually indistinguishable from the cells that make up native liver tissue.
These results offer new hope for the millions of people suffering from, or at risk of developing, liver failure—an increasingly common condition that results in progressive and irreversible loss of liver function. At present, the only option is a costly liver transplant. So, scientists have long looked to stem cell technology as a potential alternative. But thus far they have come up largely empty-handed.
“Earlier studies tried to reprogram skin cells back into a pluripotent, stem cell-like state in order to then grow liver cells,” explained Dr. Ding, one of the paper’s senior authors, who is also a professor of pharmaceutical chemistry at UCSF, with which Gladstone is affiliated. “However, generating these so-called induced pluripotent stem cells, or iPS cells, and then transforming them into liver cells wasn’t always resulting in complete transformation. So we thought that, rather than taking these skin cells all the way back to a pluripotent, stem cell-like state, perhaps we could take them to an intermediate phase.”
This research, which was performed jointly at the Roddenberry Center for Stem Cell Research at Gladstone and the Broad Center of Regeneration Medicine and Stem Cell Research at UCSF, involved using a ‘cocktail’ of reprogramming genes and chemical compounds to transform human skin cells into cells that resembled the endoderm. Endoderm cells are cells that eventually mature into many of the body’s major organs—including the liver.
“Instead of taking the skin cells back to the beginning, we took them only part way, creating endoderm-like cells,” added Gladstone and CIRM Postdoctoral Scholar Saiyong Zhu, PhD, one of the paper’s lead authors. “This step allowed us to generate a large reservoir of cells that could more readily be coaxed into becoming liver cells.”
Next, the researchers discovered a set of genes and compounds that can transform these cells into functioning liver cells. And after just a few weeks, the team began to notice a transformation.
“The cells began to take on the shape of liver cells, and even started to perform regular liver-cell functions,” said UCSF Postdoctoral Scholar Milad Rezvani, MD, the paper’s other lead author. “They weren’t fully mature cells yet—but they were on their way.”
Now that the team was encouraged by these initial results in a dish, they wanted to see what would happen in an actual liver. So, they transplanted these early-stage liver cells into the livers of mice. Over a period of nine months, the team monitored cell function and growth by measuring levels of liver-specific proteins and genes.
Two months post-transplantation, the team noticed a boost in human liver protein levels in the mice, an indication that the transplanted cells were becoming mature, functional liver cells. Nine months later, cell growth had shown no signs of slowing down. These results indicate that the researchers have found the factors required to successfully regenerate liver tissue.
“Many questions remain, but the fact that these cells can fully mature and grow for months post-transplantation is extremely promising,” added Dr. Willenbring, associate director of the UCSF Liver Center and the paper’s other senior author. “In the future, our technique could serve as an alternative for liver-failure patients who don’t require full-organ replacement, or who don’t have access to a transplant due to limited donor organ availability.”
The Latest on: Regenerative medicine
[google_news title=”” keyword=”Regenerative medicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Regenerative medicine
- Organicell Regenerative Medicine, Inc. (OCELD)on December 7, 2023 at 1:12 pm
Up Last 7 Days N/A N/A N/A N/A Up Last 30 Days N/A N/A N/A N/A Down Last 7 Days N/A N/A N/A N/A Down Last 30 Days N/A N/A N/A N/A ...
- Study links back pain to a subtype of cells in spinal 'shock absorbers'on December 7, 2023 at 1:08 pm
"We've identified for the first time particular cells that could be the key to understanding disk pain," said Dmitriy Sheyn, Ph.D., research scientist in the Board of Governors Regenerative Medicine ...
- In pigs, researchers show ultrasound could be used for 3D printing inside the bodyon December 7, 2023 at 11:00 am
Researchers have successfully demonstrated a proof of concept for using a 3D printer to print biomaterials directly inside an organ.
- Novel stem cell therapy using mRNA technology may stimulate natural repair in liver diseaseon December 7, 2023 at 9:37 am
Mortality related to end stage liver disease is ranked as the 12th most common cause of death in the U.S. Liver transplantation remains the only treatment for end stage liver disease, but there is a ...
- OREF/UConn to Support Laurencin Regenerative Engineering Instituteon December 7, 2023 at 8:42 am
Dr. Laurencin told OTW, “I am very happy to see the pace in which this partnership has been formed to advance the field of Regenerative Engineering that I founded. This is a first of a kind ...
- Atlantis The Royal on the Future of Luxury Wellness Travelon December 7, 2023 at 6:00 am
At Atlantis The Royal, diverse wellness offerings have transformed the guest journey throughout the ultra-luxury resort.
- Wearable Ultrasounds: A Sonic Leap In Regenerative Medicineon December 7, 2023 at 5:31 am
This story is part of a series on the current progression in Regenerative Medicine. This piece discusses advances in wearable devices. In 1999, I defined regenerative medicine as the collection of ...
- Wellth introduces natural chronic disease reversal solutions on the occasion of their one-year anniversaryon December 7, 2023 at 12:58 am
Wellth, UAE's premier integrative medicine hub, proudly commemorates its inaugural year dedicated to operational excellence and reversal of chronic diseases.
- Weather Changes And Arthritis: Expert Reveals The Connection And Role Of Regenerative Medicineon December 6, 2023 at 10:39 pm
The weather-arthritis link is still debated, but regenerative medicine brings hope to relieve arthritis effects.
- Global Amniotic Membrane Market Research Report 2023-2030: Rising Expenditure in R&D in the Field of Stem Cells and Regenerative Medicineon December 6, 2023 at 6:48 am
The "Amniotic Membrane Market Size, Share & Trends Analysis Report By End-use (Hospitals, Specialty Clinics), By Product, By Application, By Region, And Segment Forecasts, 2023 - 2030" report has been ...
via Bing News